Acadian Asset Management’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-275,069
| Closed | -$191K | – | 1964 |
|
|
2023
Q1 | $191K | Hold |
275,069
| – | – | ﹤0.01% | 1264 |
|
|
2022
Q4 | $246K | Buy |
+275,069
| New | +$246K | ﹤0.01% | 1232 |
|
|
2021
Q4 | – | Sell |
-5,253
| Closed | -$24K | – | 1896 |
|
|
2021
Q3 | $24K | Buy |
5,253
+517
| +11% | +$2.36K | ﹤0.01% | 1648 |
|
|
2021
Q2 | $33K | Buy |
+4,736
| New | +$33K | ﹤0.01% | 1871 |
|
|
2021
Q1 | – | Sell |
-29,618
| Closed | -$137K | – | 2394 |
|
|
2020
Q4 | $137K | Buy |
29,618
+19,804
| +202% | +$91.6K | ﹤0.01% | 1660 |
|
|
2020
Q3 | $38K | Buy |
+9,814
| New | +$38K | ﹤0.01% | 1930 |
|